In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OmniGuide's flexible laser tech:

This article was originally published in Clinica

Executive Summary

OmniGuide has CE-marked for sale in Europe its flexible CO2 laser fibres for use in minimally-invasive surgery. Its OtoBeam and BeamPath systems, which are already approved in the US, can now be sold in all countries that accept the CE-mark, said the Cambridge, Massachusetts firm. Most CO2 lasers have a rigid articulating arm that limits the surgeon to procedures where a "line-of-sight" from outside the patient's body is possible, the firm claimed. The OmniGuide fibre, which is fitted to this existing base of CO2 laser systems, allows physicians to place the fibre into the patient's body under endoscopic guidance to treat lesions within the skull base, airway and larynx.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049351

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel